Navigation Links
Cancer Survivors Face Tough Road Long After Treatment Ends
Date:7/30/2009

Study shows they're at increased risk of psychological distress years later

THURSDAY, July 30 (HealthDay News) -- Cancer survivors are more likely than their healthy peers to suffer serious psychological distress such as anxiety and depression, even a decade after treatment ends, new research shows.

Those who were relatively young at the time of diagnosis, unmarried, had less than a high school education, were uninsured, had other illnesses or had difficulty doing the activities of daily living were at the highest risk of psychological problems.

The study appears in the July 27 issue of the Archives of Internal Medicine.

The United States is home to 12 million cancer survivors, or 4 percent of the population, numbers that are expected to rise as cancer screening improves and Baby Boomers age, according to the researchers, from Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston.

To gauge the long-term psychological impact of the disease, they analyzed mental health and medical data on 4,636 adults who'd survived cancer and 122,220 who had never had cancer. The data was collected between 2002 and 2006 by the National Health Interview Survey, which is conducted yearly by the U.S. Census Bureau.

During a follow-up period of at least five years and an average of 12 years, about 5.6 percent of cancer survivors were found to have experienced severe psychological distress within the previous month, compared with 3 percent of those without cancer.

Dr. James Zabora, a former associate professor of oncology at Johns Hopkins School of Medicine who has researched cancer and mental health issues, said the study was well done but that the measure of mental health has not been scientifically validated for use in cancer survivors.

In fact, he said, he suspected the incidence of mental health issues among cancer survivors may be higher.

"It's a well-desig
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Texas on Top of Cancer Research: Dallas Regional Chamber Hosts Forum on New $3 Billion Fund
2. Brain Scan May Help Predict Cancer Drug Response
3. Living Green Marketplace Announces the Cancer Care Wellness Box to Bring Comfort to Cancer Patients During Medical Treatment
4. Ritas Squeezes Pediatric Cancer with $451,000 Donation
5. Chinese women join global breast cancer trial
6. AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
7. National Cancer Coalition Announces Angel Grant Recipients
8. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
9. HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans
10. New Spanish-Language Consumer Guides Compare Treatments for Depression, Prostate Cancer and Other Conditions
11. Tanning Beds Now Listed as Top Cancer Risk

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Survivors Face Tough Road Long After Treatment Ends
Cancer Survivors Face Tough Road Long After Treatment Ends
(Date:11/21/2009)... Eric J. Hall, president ...ndation of America (AFA) issued the following stat...ent detection as part of the new annual wellness f...tection and Affordable Care Act" that was int... York, NY (PRWEB) November 21, 2009 -- Eric J. Hal...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Fir...today that a Special Meeting of Shareholders will ...of the Meeting is to consider approval of two spec...o approve and authorize the sale of all or substan... on the terms provided for in the asset purchase a...
(Date:11/20/2009)... Senators and Congressmen...ouble Over their Health Care Vote , ...9 -- Senators and congressmen running for re-elect... political guru Charlie Cook, may come to regret v...h care bill, according to a breaking Zogby Interna...
(Date:11/20/2009)..., , HAIFA, Israel, November 20 /PRNe...e Corp. (CVSL.OB), http://www.CVSLMEDICAL.COM , a...ery technology, today announced that,the company,s... applications,in Europe, Canada and the Far East f...ewire" applicable for all angioplasty (PCTA) proce...
(Date:11/20/2009)... An editorial published online November 20 in the...ses the exaggerated fears and hopes that often app...rial provides guidance for both the media and jour...hwartz, M.D., M.S., and Steven Woloshin, M.D., M.S...tmouth Institute for Health Policy and Clinical Pr...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...is being issued,by the Federation of Clinical Immu...ician scientists from 58 countries across the glob...nical immunology, When: Wednesday, June 4-Monday,...ay, June 4, 8:30 am to 4:45 pm, Salon D, Fourth ...
...certain type of prostate cancer have been shown to...lus prednisone in an international trial led by Or...researchers. , The research involved men with an... therapies. This is the most advanced form of pro...
... of Short-Term Treatment of Chronic,Idiopathic Thr...xoSmithKline (NYSE: GSK ),today announced that th...ology Drugs Advisory Committee (ODAC) unanimously ...thic,thrombocytopenic purpura (ITP). The FDA advis...
...ating an effective launch,team is imperative to en....,A product,s promotion relies heavily on the succ... ensure that they create effective, cross-function...leading companies are utilizing to create effectiv...
...ction of toxic free radicals from hypertension, st...ews) -- Tests on mice suggest that the drug BH4 ma...rged hearts, says a Johns Hopkins University study...d phenylalanine can cause brain damage. , In this ...
...remieres "You: The Exhibit" Using,Cutting-Edge Sci...gine seeing yourself in,30 years, changing your ph...ects of lifestyle choices, or experiencing life in...so known as The,Health Museum, will premiere You: ...
Other Medicine News:Health News:World-Renowned Scientists to Lead Immunology Course 2Health News:World-Renowned Scientists to Lead Immunology Course 3Health News:World-Renowned Scientists to Lead Immunology Course 4Health News:OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 3Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 4Health News:Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence 2Health News:Genetic Disorder Drug Helps Reverse Heart Muscle Enlargement 2Health News:Nation's Only Health Museum Makes 'You' Sole Focus of New Exhibit Gallery 2Health News:Nation's Only Health Museum Makes 'You' Sole Focus of New Exhibit Gallery 3
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Medical Adhesives and Sealants - A US Market R...2/Medical-Adhesives-and-Sealants---A-US-Market-Rev...mp;utm_campaign=prnewswire ,, The use of medi...in medical devices and equipments. Cutting edge me...
(Date:11/20/2009)...ewswire-FirstCall/ -- BD (Becton, Dickinson and Co...on of its acquisition of HandyLab, Inc., an Ann Ar...factures molecular diagnostic assays and automatio...nounced an exclusive agreement for BD to develop a...Jaguar(TM) platform, the first fully integrated mo...
(Date:11/19/2009)... -- In response to an ever-increasing number of we...Operation Pangea II, involving 24 countries, was c...zation,s International Medical Products Anti-Count...ers of buying medicines online. ,, The week lon...s and the seizure of thousands of potentially harm...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Surgery Sham Equal in Treating Compression Fracture Pain 53774 1Surgery Sham Equal in Treating Compression Fracture Pain 53774 2Surgery Sham Equal in Treating Compression Fracture Pain 53774 3PDI Reports 2009 Second Quarter Financial Results 13399 1PDI Reports 2009 Second Quarter Financial Results 13399 2PDI Reports 2009 Second Quarter Financial Results 13399 3PDI Reports 2009 Second Quarter Financial Results 13399 4PDI Reports 2009 Second Quarter Financial Results 13399 5PDI Reports 2009 Second Quarter Financial Results 13399 6PDI Reports 2009 Second Quarter Financial Results 13399 7PDI Reports 2009 Second Quarter Financial Results 13399 8PDI Reports 2009 Second Quarter Financial Results 13399 9Orexigen 28R 29 Therapeutics to Speak at Canaccord Adams Global Growth Conference 13397 1
...ry Support Program, HAMBURG, Germany and OXFORD, ... AG (Frankfurt Stock Exchange: EVT) announced toda.... (Osaka, Japan) signed a new drug,discovery agree...laboration applies Evotec,s proprietary fragment-b...ntify novel, small molecular weight,compounds acti...
...oniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), a b...unced an agreement with W. C. Heraeus GmbH for the...ctive pharmaceutical,ingredient (API). Poniard is ...ct candidate, in four clinical trials, including t...g cancer, and is developing picoplatin as a,potent...
Other Medicine Technology:Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 2Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec 3Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin 2Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin 3
...ffective nonionic contrast medium well established...ide, more than 250 million doses of iopamidol have...of radiological procedures, Isovue offers desired ...ncentrations and packaging options. Isovue Multipa...
...administration by power injector, OptiMARK is a g...of the brain, spine and liver. OptiMARK has conve...of contrast, packaged for efficient, problem-free ...lity and diagnostic accuracy you expect from a gad...
...anced Magnetics' oral gastrointestinal imaging age... other abdominal structures and physiology. MRI im... contrast agents is difficult because these organs...he loops of the bowel. When GastroMARK is ingested...
...molar contrast medium (IOCM) available in the U.S....QUE was designed for patient safety and comfort. V...ed with sodium and calcium in a ratio equivalent t...for use in children over one year of age. With an ...
Medicine Products: